laekna news - Search News

Laekna, obesity and Eli Lilly

Reuters on MSN · 4d

China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug

Eli Lilly and Hong Kong-listed Laekna will collaborate to develop an experimental obesity drug that aims to help patients lose weight while preserving muscle, the biotech said on Wednesday. WHY IT MATTERS Lilly is aiming to strengthen its position as a leader in the obesity treatment market,

Business Insider · 3d

Eli Lilly and China-based biotech Laekna team on obesity drug

Earlier on Wednesday, Laekna, “a global biotech company focused on novel drug development for metabolic and cancer diseases,” accoding to its

Seeking Alpha · 3d

Eli Lilly in pact with Chinese biotech for novel weight loss therapy

Eli Lilly (LLY) partners with Laekna Therapeutics to develop an obesity therapy that avoids muscle loss. Read more here.

Lilly Partners With Chinese Biotech to Advance Muscle-Sparing Obesity Treatment

Lilly will provide the funding and expertise to advance Laekna’s LAE102, a first-in-class monoclonal antibody targeting the ...

Business Wire4d

Laekna Announces a Clinical Collaboration with Lilly to Develop LAE102, a Novel Monoclonal Antibody Targeting Activin Receptor Type 2A for The Treatment of Obe…

Laekna, Inc. (2105.HK) (“Laekna”), a global biotech company focused on novel drug development for metabolic and cancer ...

3d

Laekna, Inc. Announces Share Placement to Raise HK$230 Million

Laekna, Inc. (HK:2105) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...

阿思達克財經網3d

LAEKNA-B Last Slumps 7%+ after Announcing Shr Placing on 48% Rally Ytd

LAEKNA-B (02105.HK) announced a share placing immediately after a 48% share surge yesterday (20th). Today (21st), it opened ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results